Acinetobacter baumannii is a Gram-negative opportunistic bacterium that causes difficult-to-treat nosocomial infections. Due to its multidrug resistance and persistence in clinical environments, A. baumannii is classified by the World Health Organization as a critical priority pathogen [1]. One of the key virulence factors of A. baumannii is the polysaccharide capsule, which enables evasion of host immune defences [2], [3].
Macrophages are among the first innate immune effectors and play an important role in controlling bacterial spread. These cells are involved in phagocytosis, antigen presentation, and regulation of inflammation [4]. During infection, macrophages can undergo different inflammatory and non-inflammatory forms of cell death. The balance between these pathways influences the outcome of the immune response [5]. This study aimed to investigate how the polysaccharide capsule of A. baumannii modulates apoptotic (non-inflammatory) and pyroptotic (inflammatory) cell death pathways in macrophages.
We used a capsulated clinical A. baumannii strain and its non-capsulated mutants. In vitro infections were performed using murine J774A.1 and human THP-1 macrophages. Viability of macrophages was assessed by fluorescence microscopy, while apoptosis and pyroptosis markers were analysed by Western blot. Apoptosis was evaluated by detecting activation of the effector caspase-3 (Casp-3), while pyroptosis was assessed by detecting formation of the N-terminal gasdermin D fragment (GSDMD-N) and secretion of the pro-inflammatory cytokine interleukin-1β (IL-1β).
The non-capsulated ΔgalU mutant resulted in increased viability of J774A.1 and THP-1 macrophages and induced weaker activation of Casp-3 compared to the capsulated strain. To assess whether this effect is strain-dependent, Casp-3 activation was also analysed using another capsulated clinical isolate and its non-capsulated Δwza mutant. The study revealed that the Δwza non-capsulated mutant likewise induced significantly weaker Casp-3 activation. In contrast, loss of the polysaccharide capsule did not significantly affect GSDMD-N formation and IL-1β secretion in J774A.1 and THP-1 cells.
Our findings show that the loss of A. baumannii polysaccharide capsule significantly increased macrophage viability and reduced activation of the effector apoptotic caspase-3 in both cell lines. However, the loss of bacterial capsule did not affect pyroptotic responses. These results indicate that the polysaccharide capsule of A. baumannii induces apoptotic rather than pyroptotic signalling in J774A.1 and THP-1 macrophages during infection.